Shire pipeline 'to add $3bn in sales by 2020'

Shire says drug candidates in its pipeline will contribute $3bn in sales by 2020. The company set out its wares at an R&D day in New York eight weeks after AbbVie pulled out of a $53bn offer for the rare disease specialist following the US Treasury's tightening of tax rules (scripintelligence.com, 16 October 2014).

"Shire's clear and focused strategy has enabled us to transform our pipeline with 22 programs in the clinic, the most...